... Heymann nephritis Masugi nephritis Nephron 50: 116-120(1988) © 1988 S. Karger A G , Basel 0028-2766/88/0502 01I6S2.75/0 The Electrophoretic Pattern of Urinary Protein in in situ Immune Complex Glomerulonephritis1 Tetsuo Morioka ', Hiroshi Suganoh, Katsuyuki MatsuP', Shoji Kagami\ Fujio Shimizua...

... responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Active membranous glomerulonephritis Nephritogenoside nephritis Soluble FXIA Heymann nephritis Nephron 1989:51:243-249 © 1989 S. Karger A G...

...Hiroshi Kawaguchi; Yutaka Yamaguchi; Motoshi Hattori; Michio Nagata; Michiko Nagata; Miyuki Kohno; Katsumi Itoh This study was undertaken to investigate the effects of dietary protein intake on renal function and pathology in unilaterally nephrectomized rats with passive Heymann nephritis (PHN). 60...

...L.S. Milner; D. Lotan; M. Mills; P.R. Goodyer; J.S.C. Fong; B.S. Kaplan Colchicine was given to rats in the heterologous phase of passive Heymann nephritis to see whether this drug could reduce proteinuria. Treatment with 0.06 mg/day for 14 days caused significant reductions in proteinuria...

... or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Heymann nephritis Enzyme-linked immunosorbent assay Proliferative...

... Engelbreth-Holm-Swarm sarcoma Anti-Engelbreth-Holm-Swarm sarcoma antiserum Heymann nephritis Antiglomerular basement membrane antiserum Nephrotoxicity © 1987 S. Karger AG, Basel 1987 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part of this publication may...

...Seiya Okuda; Yukinori Oh; Kaoru Onoyama; Satoru Fujimi; Teruo Omae In order to investigate the influence of diabetes mellitus on immune complex-mediated nephritis, we produced Heymann nephritis in streptozotocin-induced diabetic rats (DM-HN group) in which the clinical course for 24 weeks...

...Seiya Okuda; Yukinori Oh; Hiroshi Tsuruda; Kaoru Onoyama; Satoru Fujimi; Teruo Omae; Masatoshi Fujishima The effects of nephron loss on the clinical and histological picture of experimental membranous nephropathy were examined for 18 weeks in five-sixths nephrectomized rats with Heymann nephritis...

... antigen, Fx1A. The rabbit antiserum was reactive with antigens normally present in the brush border regions of proximal tubules of human and rat kidneys and in the glomerular deposits of rats with Heymann nephritis. However, renal tubular antigens were not detectable in any of the cases of human...

...* 0602, a specific haplotype of human major histocompatibility complex (MHC), in Japanese patients. To investigate the role of MHC in the development of rat Heymann nephritis (HN), an animal model of membranous nephropathy, a monoclonal antibody (mAb) specific to rat MHC class II antigen (RT1B...

.... Methods: Rats with and without autoimmune Heymann nephritis were treated with a NO synthase inhibitor L-NAME (50 mg/100 ml) and/or an ACE inhibitor captopril (20 mg/100 ml) in drinking water for 12 weeks. Urinary cGMP excretion was used as an indirect measure of NO activity. Blood pressure, urinary...

... of flosulide and aspirin were studied during the autologous phase of passive Heymann nephritis (PHN) in rats. Female Wistar rats were injected i.v. with 1 ml of Fx1A antiserum at day 1. From day 7 to day 14 they received either aspirin (aspirin, 50 mg/day), flosulide, (0.75 mg/day) or vehicle p.o. The kidney...